Zai Lab

Zai Lab CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Zai Lab (ZLAB) as of Nov 22, 2026 is -8.90 %. In the previous year, CapEx to Operating Cash Flow Ratio was -28.63 % — a change of -68.91% (higher).

CapEx/OCF

-8.90 %

YoY

-68.91%

Last updated:

CapEx to Operating Cash Flow Ratio of Zai Lab is 2025 -8.90 % . CapEx to Operating Cash Flow Ratio of Zai Lab was 2024 -28.63 % . It decreases by -68.91% higher compared to the previous year.

The Zai Lab CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
-10.37 USD
Jan 1, 2019
-7.98 USD
Jan 1, 2020
-4.94 USD
Jan 1, 2021
-3.45 USD
Jan 1, 2022
-6.80 USD
Jan 1, 2023
-4.28 USD
Jan 1, 2024
-28.63 USD
Jan 1, 2025
-8.90 USD
The Zai Lab CapEx/OCF history
YEARCapEx/OCFYoY
-8.90 %-68.91%
-28.63 %+568.27%
-4.28 %-36.95%
-6.80 %+96.98%
-3.45 %-30.14%
-4.94 %-38.12%
-7.98 %-23.07%
-10.37 %-63.17%
-28.17 %+306.28%
-6.93 %+7.64%
-6.44 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zai Lab Stock analysis

What does Zai Lab do? Zai Lab Ltd, based in Pudong, China, is a biopharmaceutical company operating in the Health Care sector. It develops and commercializes innovative treatments for oncology, immunology, neuroscience, and infectious diseases. The company offers products such as Zejula for ovarian cancer, VYVGART for myasthenia gravis, NUZYRA for bacterial infections, Optune for brain tumors, Qinlock for gastrointestinal tumors, Xacduro for bacterial pneumonia, and Augtyro for lung cancer. Zai Lab collaborates with leading pharmaceutical firms including Pfizer and Amgen. Zai Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zai Lab stock

CapEx to Operating Cash Flow Ratio of Zai Lab is -8.90 % in 2025.

CapEx to Operating Cash Flow Ratio of Zai Lab changed from -28.63 % to -8.90 %, representing a -68.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Zai Lab since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Zai Lab with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Zai Lab

All Key Metrics — Zai Lab